• Drosophila Keap1–Lamin Control of Chromatin

  2026-08-18

  The reference study identifies a functional interaction between Drosophila Keap1 and the B-type lamin Dm0, linking xenobiotic and oxidative-response signaling to nuclear lamina organization and heterochromatin distribution. Its combined localization, chromatin-marker, and genetic evidence suggests that dKeap1 can influence development partly by remodeling higher-order nuclear architecture.

• Angiotensin I: A Decapeptide Assay Framework

  2026-08-18

  Angiotensin I is more than a precursor of angiotensin II: it is a controllable substrate for dissecting renin-angiotensin system research, cardiovascular disease mechanisms, and peptide-dependent assay behavior. This guide connects molecular identity, experimental design, and recent spike–receptor binding evidence to improve interpretation and reproducibility.

• FOXM1 and ceRNA Biomarkers in Female LUAD

  2026-08-17

  This study integrates public transcriptomic datasets, ceRNA-network analysis, immune-related computational profiling, and cellular validation to examine FOXM1 in female lung adenocarcinoma. Its central finding is a proposed DGCR5–miR-204-5p–FOXM1–estrogen receptor axis, although the incomplete validation of DGCR5 highlights the need for further mechanistic testing.

• Nebivolol hydrochloride: β1 Signaling Workflow

  2026-08-17

  Nebivolol hydrochloride enables a focused workflow for β1-adrenergic receptor signaling research, from concentration-response studies to pathway-level validation. Its negative result in a drug-sensitized yeast mTOR screen is equally useful, helping researchers distinguish cardiovascular receptor pharmacology from nonspecific TOR-pathway activity.

• p38α Dephosphorylation by Dual-Action Inhibitors

  2026-08-16

  A recent preprint shows that selected kinase inhibitors can do more than block p38α catalytic activity: they can also accelerate WIP1-mediated dephosphorylation of the kinase activation loop. Biochemical and X-ray structural data connect this effect to an inhibitor-stabilized activation-loop conformation, offering a framework for designing inhibitors that promote both immediate inhibition and durable pathway shutdown.

• Silybin A: Designing Mechanism-First Liver Assays

  2026-08-15

  Silybin A offers a defined molecular system for Silymarin-related liver research, but its value depends on separating solvent, viability, redox, and pathway effects. This article uses a mechanistic hepatocellular carcinoma study as a model for stronger assay design while clearly distinguishing evidence for Silybin A from evidence for other phytochemicals.

• H2S Deficiency and ER Stress in Diabetic Cardiomyopathy

  2026-08-14

  The reference study identifies reduced endogenous hydrogen sulfide production as a mechanistically relevant feature of lipotoxic injury in diabetic cardiomyopathy. Using patient samples, streptozotocin-induced diabetic rats, and palmitate-treated AC16 cardiomyocytes, it links H2S deficiency with endoplasmic reticulum stress and shows that H2S donation or ER-stress inhibition reduces cellular injury.

• Fulvestrant (ICI 182,780) Workflow Guide

  2026-08-14

  Fulvestrant (ICI 182,780) combines high-affinity ER antagonism with ERα degradation, making it useful for separating receptor-dependent signaling from downstream survival effects. This guide translates the compound’s breast cancer applications and a mechanistically informative estrogen-receptor study into practical dosing, assay, combination-treatment, and troubleshooting workflows.

• Y-27632 for MSC Mechanobiology Workflows

  2026-08-13

  Use Y-27632 as a reversible ROCK inhibitor to separate cell-shape-driven mechanics from downstream fate decisions in mesenchymal stromal cells. This workflow combines geometric micropatterning, focal-adhesion imaging, actin organization, and YAP readouts for controlled cytoskeletal dynamics modulation.

• Nanozymes Target Intramacrophage Bacteria in CRC

  2026-08-13

  The reference study develops a macrophage-targeted, self-activating polymeric nanozyme that combines ferrocene chemistry with artesunate to eliminate intracellular Fusobacterium nucleatum in colorectal cancer. By reducing a bacterial driver of immunosuppression, the platform remodeled macrophage behavior and improved the response to CD47 blockade, while also suggesting useful lysosomal imaging readouts for mechanistic validation.

• TCEP Hydrochloride: Mechanism and Workflows

  2026-08-12

  Tris(2-carboxyethyl) phosphine hydrochloride, also called TCEP hydrochloride, is a water-soluble, thiol-free reagent for disulfide bond reduction. Its documented uses include protein digestion enhancement, hydrogen-deuterium exchange analysis, reduction of dehydroascorbic acid, and selected organic synthesis workflows.

• Mouse Tissue Lysis Kit K1038: Workflow Guide

  2026-08-12

  The Mouse Tissue Lysis Kit (K1038) supports rapid digestion of mouse tail, toe, and ear tissues for direct PCR-based genotyping and DNA analysis. It is intended for molecular biology research and direct template preparation, not diagnostic, clinical, or medical use.

• WEHI-539: Practical BCL-XL Inhibitor Workflows

  2026-08-11

  WEHI-539 is a selective BCL-XL inhibitor for separating BCL-XL dependence from broader mitochondrial apoptosis effects. This guide converts its biochemical potency and BAK-dependent mechanism into practical workflows for apoptosis assays, glioblastoma combination studies, and cancer stem cell sensitization.

• Nebivolol hydrochloride for β1 Signaling Assays

  2026-08-11

  Build cleaner β1-adrenergic receptor experiments with Nebivolol hydrochloride, a potent β1-adrenoceptor antagonist suited to concentration-response, pathway, and selectivity studies. The compound also provides a useful negative comparator when a drug-sensitized yeast platform is used to test TOR or mTOR-related activity.

• Hexa His Tag Peptide: From Elution to Translation

  2026-08-10

  Competitive elution is more than a recovery step: it can determine whether a protein interaction dataset reflects native biology or purification artifacts. This thought-leadership article connects the mechanism of the Hexa His tag peptide with assay design, translational reproducibility, and lessons from recent CARMIL research on state-dependent protein regulation.

14466 records 1/965 page Next 12345 下5页 Last page